Glaucoma and microglia-induced neuroinflammation
Frontiers in Ophthalmology · 27.02.2023 · 3
DOI: 10.3389/fopht.2023.1132011 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Ophthalmology, online erschienen am 27.02.2023. Verfasst von Makoto Ishikawa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Glaucoma is a multifactorial neurodegenerative disease characterized by a progressive optic neuropathy resulting in visual field defects. Elevated intraocular pressure (IOP) is the greatest risk factor for the development of glaucoma, and IOP reduction therapy is the only treatment currently available. However, there are many cases in which retinal degeneration progresses despite sufficient control of IOP. Therefore, it is important to elucidate the pathophysiology of glaucoma that is resistant to current IOP lowering therapies. Experiments using animal glaucoma models show the relationships between microglial neuroinflammatory responses and damage of retinal ganglion cells (RGCs). Inhibition of neuroinflammatory pathways associated with microglial activation appears to be neuroprotective, indicating that microglia may be an important therapeutic target for RGC protection. In this review, we will focus on microglia-induced neuroinflammation in the pathogenesis of glaucoma to offer new insights into the possibility of developing novel neuroprotective therapies targeting microglia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan.
- Department of Ophthalmic Imaging and Information Analytics, Tohoku University Graduate School of Medicine, Sendai, Japan.
- Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, MO, United States.
- Center for Brain Research in Mood Disorders, Washington University School of Medicine, St. Louis, MO, United States.
- Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States.
- Department of Advanced Ophthalmic Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Förderung
- NIMH NIH HHS
- Japan Society for the Promotion of Science
Zitieren
APA
Ishikawa, M., Izumi, Y., Sato, K., Sato, T., Zorumski, C. F., Kunikata, H., & Nakazawa, T. (2023). Glaucoma and microglia-induced neuroinflammation. Frontiers in Ophthalmology, 3. https://doi.org/10.3389/fopht.2023.1132011
Vancouver
Ishikawa M, Izumi Y, Sato K, Sato T, Zorumski CF, Kunikata H, et al. Glaucoma and microglia-induced neuroinflammation. Frontiers in Ophthalmology. 2023;3. doi:10.3389/fopht.2023.1132011
BibTeX
@article{Ishikawa2023,
author = {Ishikawa, Makoto and Izumi, Yukitoshi and Sato, Kota and Sato, Taimu and Zorumski, Charles F and Kunikata, Hiroshi and Nakazawa, Toru},
title = {Glaucoma and microglia-induced neuroinflammation},
journal = {Frontiers in Ophthalmology},
year = {2023},
volume = {3},
doi = {10.3389/fopht.2023.1132011}
}
EUVIMED